ERBB2 homodimerization

Stable Identifier
R-HSA-1227964
Type
Reaction [dissociation]
Species
Homo sapiens
Compartment
Synonyms
2 x ERBB2:HSP90:CDC37 => ERBB2 homodimer
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

ERBB2, present at low levels in normal cells, is overexpressed in cancer cells with ERBB2 gene amplification, leading to growth factor-independent activation of ERBB2 signaling through formation of ERBB2 homodimers (Pickl and Ries 2009, Maadi et al. 2018). It is assumed that during homodimerization, similar to normal heterodimerization with ligand-activated ERBB family members, chaperone proteins HSP90 and CDC37, as well as ERBB2IP, dissociate from ERBB2 (Borg et al. 2000, Xu et al. 2001, Citri et al. 2004).

Literature References
Participants
Participant Of
Disease
Name Identifier Synonyms
cancer 162 malignant tumor, malignant neoplasm, primary cancer
Authored
Reviewed
Created